Cara Therapeutics' Stock Buoyed By Positive Korsuva Data For Post-Op Pain

 
• By Sten Stovall
  
Laparoscopic equipment
Phase II/III Korsuva trial met its primary endpoint in patients undergoing abdominal surgeries • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D